SGRY vs EHC โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
EHC Captures Institutional Edge (2โ2 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Encompass Health Corporation Common Stock (EHC) driven by superior Valuation, Growth & Margin while SGRY counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, SGRY trades at N/M Forward P/E with 13.2% operating margin (-0.8% YoY revenue) versus EHC at 19.4x Forward P/E and 18.4% operating margin (+8.9% YoY). In options structure, SGRY sits in SURGE (34th %ile IV; Dealer Gamma Walls on Pro) against EHC sits in CONSOLIDATION (8th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | SGRY Revenue | EHC Revenue | SGRY Op. Margin | EHC Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $1.77B | $4.28B | 4.4% | 13.0% | EHC |
| FY2019 | $1.83B | $4.61B | 12.9% | 13.3% | EHC |
| FY2020 | $1.86B | $3.57B | 9.8% | 15.8% | EHC |
| FY2021 | $2.23B | $4.01B | 13.6% | 13.9% | EHC |
| FY2022 | $2.54B | $4.35B | 13.6% | 12.4% | SGRY |
| FY2023 | $2.74B | $4.80B | 12.0% | 7.3% | SGRY |
| FY2024 | $3.11B | $5.37B | 11.2% | 8.5% | SGRY |
| FY2025 | $3.31B | $5.94B | 11.8% | 9.5% | SGRY |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | SGRY | EHC | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $3.5B | $13.0B | Larger Scale | EHC |
| Trailing P/E Ratio Valuation | N/M | 21.2x | Lower Multiple | EHC |
| Forward P/E Ratio Valuation | N/M | 19.4x | Lower Multiple | EHC |
| Revenue Growth (YoY) Growth | -0.8% | +8.9% | Higher Growth | EHC |
| Operating Margin (TTM) Profitability | 13.2% | 18.4% | Higher Margin | EHC |
| Net Profit Margin Profitability | -2.6% | 10.2% | Higher Margin | EHC |
| Return on Equity (ROE) Capital Efficiency | 2.1% | 25.1% | Higher ROE | EHC |
| 52-Week Range Position Momentum | 97% ($11โ$27) | 80% ($93โ$144) | Stronger Trend | SGRY |
| Beta / 30D Volatility Risk Regime | 0.87ฮฒ ยท 166% Vol | -0.10ฮฒ ยท 40% Vol | Lower Realized Risk | EHC |
| Unified Institutional Score Composite Signal | 29.6 / 100 (SELL) | 52.0 / 100 (HOLD) | Higher Composite | EHC |